Jianmei Hou - Concepedia

Author

Jianmei Hou

Xiangya Hospital Central South University ORCID

Also Known As

Hou J, J M Hou, J. Hou, J.M. Hou, Jian-Mei Hou, Jianmei Hou

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Xiangya Hospital Central South University Central South University Fudan University Shanghai Cancer Center Peking University Peking University Cancer Hospital

About

Jianmei Hou is an author at Xiangya Hospital Central South University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	750
2	Obstetrics	2	2	54
3	Pathology	2	2	675
4	Health Sciences	1	1	12
5	Cell Biology	1	1	438

Jianmei Hou

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Evaluation and Prognostic Significance of Circulating Tumor Cells in Patients With Non–Small-Cell Lung Cancer Matthew Krebs, Robert Szczepaniak‐Sloane, Lynsey Priest, Journal of Clinical Oncology	2011	863
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer Jianmei Hou, Matthew Krebs, Tim Ward, American Journal Of Pathology Cancer ResearchOncologyMedicineBiological MicroenvironmentsMetastasis Biology	2011	438
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy Jianmei Hou, Alastair Greystoke, Lee Lancashire, American Journal Of Pathology Prognostic BiomarkersMedicineCirculating Tumor CellsPathologyBronchial Neoplasm	2009	237
Niraparib maintenance therapy in patients with platinum-sensitive recurrent ovarian cancer using an individualized starting dose (NORA): a randomized, double-blind, placebo-controlled phase III trial☆ Xiaohua Wu, Jianqing Zhu, Rutie Yin, Annals of Oncology	2021	195
Treatment With Niraparib Maintenance Therapy in Patients With Newly Diagnosed Advanced Ovarian Cancer Ning Li, Jianqing Zhu, Rutie Yin, JAMA Oncology	2023	143
Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5) Ning Li, Jianqing Zhu, Rutie Yin, Gynecologic Oncology Prime StudyMaintenance TreatmentMedicineCancer ManagementGynecology	2022	42
Sources of organic matter and carbon stocks in two mangrove sediment cores and surface sediment samples from Qinglan Bay, China Dehao Tang, Xingjian Liu, Zhen Xia, The Science of The Total Environment	2023	31
Nurses’ Willingness and Demand for Internet +home Care Services and Its Influencing Factors in Different Levels of Hospitals in China – A Nationwide Survey Guiyuan Ma, Jianmei Hou, Sha Peng, Risk Management and Healthcare Policy	2022	23
Nurses’ knowledge of peripherally inserted central catheter maintenance and its influencing factors in Hunan province, China: a cross-sectional survey Binbin Xu, Jinghui Zhang, Jianmei Hou, BMJ Open	2020	22
Thrombotic risk factors in patients with superior vena cava syndrome undergoing chemotherapy via femoral inserted central catheter Jianmei Hou, Jinghui Zhang, Mengdan Ma, Thrombosis Research ThrombosisVenous ThrombosisPatient SafetySyndrome Undergoing ChemotherapyVascular Surgery	2019	21

Page 1